Subsequent studies showed that a transferrin-conjugated nanoparticle delivery system for synthetic miR-29b (Tf-NP-miR-29b) suppressed AML growth, impaired colony formation, and reduced cell viability in AML patient samples. Here, TF is linked to acute myeloid leukemia.